Abstract:Background: Caffeine is the most widely consumed psychostimulant. Despite this, the effects of acute caffeine intake on brain metabolite levels remain largely unknown. We aimed to investigate the effect of acute caffeine intake on brain metabolite concentrations in different caffeine consumption habit groups and to explore the association between metabolite changes and sleepiness. Methods: Forty-five healthy adults were divided into groups based on their daily caffeine consumption: ≥1 cup/day, <1 cup/day, and no consumption. The exclusion criteria were the presence of neurological disorder, habitual consumption of mind-altering substances, and individuals who were unable to undergo magnetic resonance imaging. Mescher-Garwood point resolved spectroscopy and conventional spectroscopy data were acquired at 3 Tesla from voxels in the thalamus and posterior cingulate cortex (PCC). Subjective sleepiness was measured with the Karolinska Sleepiness Scale. Results: The results of two-way repeated measures analysis of variance indicated a significant interaction effect between time and group for glutamate, glycerylphosphocholine and phosphocholine (GPC + PCH), myo-inositol, glutamate + glutamine (Glx), and creatine and phosphocreatine (Cr + PCr) of the thalamus (all P<0.01), and glutamate (P<0.0001), GPC + PCH (P=0.016), and Glx (P<0.0001) of the PCC. The change between pre- and post-caffeine intake results with significant reductions in γ-aminobutyric acid-positive macromolecule (GABA+) (thalamus, P=0.011), Glx (thalamus, P=0.002), glutamate (PCC, P<0.0001), and significant increments in GPC + PCH (thalamus, P=0.012 and PCC, P<0.0001), myo-inositol (thalamus, P=0.009), and Glx (PCC, P<0.0001). The change among the groups, with the ≥1 cup/day was significantly higher than the <1 cup/day or no consumption for glutamate (PCC, P=0.028), GPC (thalamus, P=0.001; PCC, P=0.026), and Cr + PCr (PCC, P=0.035); ≥1 cup/day was significantly lower than <1 cup/day and no consumption for glutamate (thalamus, P<0.0001), Cr + PCr (thalamus, P=0.003), Glx (thalamus, P=0.014), and myo-inositol (PCC, P=0.009). Bivariate correlation analysis revealed that GABA+ in the thalamus voxel (r=-0.7676; P<0.0001) was negatively correlated with subjective sleepiness. Conclusions: Higher caffeine consumption had a significant impact on brain metabolites. Magnetic resonance spectroscopy was sensitive in measuring brain metabolite fluctuations after caffeine intake, particularly the levels of GABA+ in the thalamus, which was significantly correlated with sleepiness.

EEG Microstates in Early Phase Psychosis: The Effects of Acute Caffeine Consumption

Effect of Topographic Comparison of Electroencephalographic Microstates on the Diagnosis and Prognosis Prediction of Patients with Prolonged Disorders of Consciousness.

Abnormal Cortical Activity in Postoperative Delirium Based on EEG Microstate: a Cross-Sectional Study

Neuronal Dysfunction in Individuals at Early Stage of Schizophrenia, A Resting-State Fmri Study

Abnormalities of Electroencephalography Microstates in Drug-Naïve, First-Episode Schizophrenia.

Electroencephalography microstates imbalance across the spectrum of early psychosis, autism, and mood disorders

EEG microstates as biomarker for psychosis in ultra-high-risk patients

Short-term Effects of Antipsychotic Treatment on Cerebral Function in Drug-Naive First-Episode Schizophrenia Revealed by “resting State” Functional Magnetic Resonance Imaging

15 Years of Microstate Research in Schizophrenia – Where Are We? A Meta-Analysis

Effects of Microstate Dynamic Brain Network Disruption in Different Stages of Schizophrenia

Caffeine induces age-dependent increases in brain complexity and criticality during sleep

Acute caffeine administration effect on brain activation patterns in mild cognitive impairment

Shared and distinct electroencephalogram microstate abnormalities across schizophrenia, bipolar disorder, and depression

Biomarkers for Prediction of Schizophrenia: Insights From Resting-State EEG Microstates

Electroencephalographic Microstates During Sleep and Wake in Schizophrenia

Chapter Five - Exploring the complex relationship between caffeine consumption and schizophrenia: A review of epidemiological and clinical studies

Chronic Caffeine Consumption, Alone or Combined with Agomelatine or Quetiapine, Reduces the Maximum EEG Peak, As Linked to Cortical Neurodegeneration, Ovarian Estrogen Receptor Alpha, and Melatonin Receptor 2

Alteration of intracerebral metabolites and subjective sleepiness by acute caffeine administration in adults

Concentration–effect relationships of plasma caffeine on EEG delta power and cardiac autonomic activity during human sleep

The Effect of Caffeine on Movement-Related Cortical Potential Morphology and Detection

Disrupted brain network dynamics and cognitive functions in methamphetamine use disorder: insights from EEG microstates